Home / Pharmacology / Enzymes / Reductases / Dihydrofolate Reductase / Dihydrofolate Reductase Inhibitors / CI 898 trihydrochloride

CI 898 trihydrochloride

Cat. No. 2039 1 Citation Submit a Review Datasheet / COA / SDS

Discontinued Product

CI 898 trihydrochloride (Cat. No. 2039) has been withdrawn from sale for commercial reasons.
Cat.No. 2039 - CI 898 trihydrochloride | C19H23N5O3.3HCl | CAS No. 1658520-97-8
Description: Dihydrofolate reductase inhibitor
Alternative Names: TMTX, Trimetrexate
Chemical Name: 5-Methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-2,4-quinazolinediamine trihydrochloride
Purity: ≥95% (HPLC)
Datasheet
Citations (1)
Reviews
Literature
Biological Activity Technical Data Datasheets References

Biological Activity

Potent lipophilic inhibitor of dihydrofolate reductase (DHFR) that displays antineoplastic and antiprotozoal properties. Inhibits protozoal, bacterial and human DHFR with IC50 values of 1.4, 6.1 and 3.2 nM respectively. Affects G1/S phase cell cycle progression.

Technical Data

M. Wt 478.8
Formula C19H23N5O3.3HCl
Storage Store at -20°C
Purity ≥95% (HPLC)
CAS Number 1658520-97-8
PubChem ID 45006154
Smiles NC1=NC(N)=NC(C=C3)=C1C(C)=C3CNC2=CC(OC)=C(OC)C(OC)=C2.Cl.Cl.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References

References are publications that support the biological activity of the product.

Hook et al (1986) Cell cycle effects of trimetrexate (CI-898). Cancer Chemother.Pharmacol. 16 116 PMID: 2936525

Chan and Anderson (2006) Towards species-specific antifolates. Curr.Med.Chem. 13 377 PMID: 16475929

Allegra et al (1987) Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate. J.Clin.Invest. 79 478 PMID: 2948969

View Related Products by Target

View Related Products by Product Action

View all Dihydrofolate Reductase Inhibitors

Keywords: CI 898 trihydrochloride, CI 898 trihydrochloride supplier, Dihydrofolate, reductases, inhibitors, inhibits, Antineoplastic, agent, affects, G1/S, phase, progression, DHFR, Cell, Cycle, CI898, trihydrochloride, TMTX, Trimetrexate, Reductase, Inhibitors, 2039, Tocris Bioscience

1 Citation for CI 898 trihydrochloride

Citations are publications that use Tocris products. Selected citations for CI 898 trihydrochloride include:

Sienkiewicz et al (2008) Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes. Mol Microbiol 69 520 PMID: 18557814

Reviews for CI 898 trihydrochloride

There are currently no reviews for this product. Be the first to review CI 898 trihydrochloride and earn rewards!

Have you used CI 898 trihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

New Product Guide

New Product Guide (Fall/Winter 2018/2019)

Our new product guide highlights over 190 new products added to the Tocris Bioscience range during the second half of 2018.

  • 7-TM Receptors
  • Enzymes
  • Enzyme-Linked Receptors
  • Ion Channels
  • Nuclear Receptors
  • Transporters
  • Chemogenetics
  • Epigenetics
  • Fluorescent Imaging
  • PROTACs
  • Signal Transduction
  • Stem Cells